US vs Türkiye full-body screening cost — a comparable CBC, lipid panel, ultrasound, and MRI bundle for roughly 80% less. But the honest question is whether a healthy person should get a full-body screen at all.
Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →
US self-pay executive screening versus a reported Türkiye bundle. Both prices are market estimates — no neutral source publishes a precise package price in either country, so we don't state one as fact.
| Market | Price | Context | Source |
|---|---|---|---|
| United States (self-pay, executive) | $2,000–$5,000 | Broad bloodwork + MRI/CT/ultrasound bundle; midpoint near $3,500. Largely self-pay — the ACA requires no-cost coverage only for USPSTF grade A/B services, recommended vaccines and HRSA women's and children's preventive services; a full-body package is none of these. | Market estimate (no official price list) |
| Türkiye (bundled check-up, reported) | $400–$700 | Comprehensive check-up packages at JCI-accredited hospital groups, bundled. A market estimate, ~80% less — not a neutral published price. | Reported / market estimate (hedged) |
| Germany (statutory check-up) | €0 for the patient (€41.53 fee) | The statutory 'Check-up' — history, physical exam, blood lipids and glucose, counselling — is free for the insured: once between 18 and 35, then every three years. The doctor's fee is fixed at €41.53 (326 points, 2026). A full-body MRI or CT is not part of it and is paid privately. | KV Hessen (EBM GOP 01732) · Bewertungsausschuss 2026 |
| Austria · Switzerland | free yearly · not covered | Austria: the public 'health check' is free once a year for everyone from 18. Switzerland: basic insurance pays only for listed preventive measures; the only general health examination listed is for pre-school children, so an adult check-up is not covered. | ÖGK · Swiss Health Benefits Ordinance (KLV) Art. 12c |
| US health spending / person / year | ~$14,800 | OECD health spending per person, 2024 (USD PPP) — the cost base behind US prices | OECD Health Statistics 2024 |
| Türkiye health spending / person / year | ~$2,500 | Same measure, 2024 — about one-sixth of the US cost base | OECD Health Statistics 2024 |
The savings are real and large — roughly 80% for a comparable scan and panel. But a cheaper full-body screen is only a good deal if the screen was worth doing in the first place, and for symptom-free people much of it may not be. The money question and the medicine question are separate.
A US self-pay 'executive' full-body screening is commonly quoted at roughly $2,000 to $5,000 (market estimate), with a midpoint near $3,500. In Türkiye a comparable bundled check-up is reportedly a few hundred dollars — around $400 to $700, roughly 80% less. Both figures are market estimates: no government body or professional society publishes a price for these packages.
Mostly because the whole system costs less. OECD data shows the US spent about $14,800 per person on health in 2024 versus about $2,500 in Türkiye. Facility, labor, and administrative costs are far lower abroad. Packages differ, though — compare the actual list of tests and the scanner specification, not just the price.
Not automatically for healthy people. The Cochrane review (2012, reaffirmed 2019) found that general health checks did not lower the risk of dying and mainly led to more diagnoses. A bigger panel of tests is not necessarily a better one — which is the honest question behind the price tag.
No. The American College of Radiology (2023) says there is not sufficient evidence to recommend total-body screening for people with no symptoms, risk factors or family history. A 2019 systematic review (Kwee & Kwee, 12 studies, 5,373 people) found that about a third of symptom-free people scanned had a significant or unclear incidental finding; few were ever confirmed, and each can trigger more tests, cost, and anxiety. The reviewers concluded whole-body MRI should not be offered to asymptomatic people outside research.
Not according to the evidence. The USPSTF (2018), for example, rates PSA prostate-cancer screening for men 55–69 grade C (an individual decision) and recommends against it for men 70+, because over-screening can cause more harm than benefit. 'More tests' can mean more false alarms, not more health.
Two groups. Americans priced out at home — uninsured adults are more than twice as likely as insured adults to delay or skip care over cost (KFF, 2024 data), and 28% of US adults skipped or postponed needed care over cost in the past year (KFF, 2026). And immigrant families who already travel home and add a check-up to the trip. For everyone, the value still depends on which tests are actually evidence-based.
That is the single most important number in this whole comparison. A 2019 systematic review (Kwee & Kwee) found that 32.1% of symptom-free people who get a whole-body MRI come away with a critical or indeterminate incidental finding — and that most were never verified either way. Each one can trigger more tests, more cost, and more anxiety. The American College of Radiology and the FDA likewise say there is no evidence that whole-body screening of people without symptoms does more good than harm. The reviewers concluded whole-body MRI should not be offered to asymptomatic people outside research. A scan that is 80% cheaper is no bargain if it sends a healthy person down a needless workup.
The Cochrane review of general health checks (2012, reaffirmed 2019) found they did not reduce the risk of dying and mainly increased the number of diagnoses. The USPSTF makes the same point for individual tests, rating PSA prostate screening for men 55–69 grade C and advising against it after 70. A bigger panel of tests is not automatically a better one.
Executive screens commonly bundle blood tests such as a CBC and lipid panel, an abdominal ultrasound, and sometimes a whole-body MRI. They cost a fraction abroad largely because the US spent roughly $14,800 per person on health in 2024 versus about $2,500 in Türkiye (OECD). That price gap is genuine. But the honest value of the bundle depends entirely on which of those tests is evidence-based for a person with no symptoms.
None of that changes the affordability problem at home. KFF reports that 28% of US adults skipped or postponed needed care over cost in the past year (2026 survey), and that uninsured adults are more than twice as likely as insured adults to delay or go without care because of cost. For people priced out, and for immigrant families already traveling home, adding a low-cost check-up abroad is a rational response — the key is choosing tests that are actually useful, not just cheap.
The $400–$700 Türkiye range is a reported bundle price at JCI-accredited hospital groups, triangulated from market figures rather than a neutral published tariff. The direction of the gap is not in doubt; the exact figure is honestly approximate. As always, this is a cost comparison, not medical advice — decide which screening is right with a qualified clinician before booking anything.
Wellness Vision does not book trips, sell screenings, or receive referrals. We do not recommend specific clinics, hospitals, or providers, and we name none. Package prices are market estimates; spending, survey and evidence figures come from the OECD, the Cochrane Library, peer-reviewed radiology research, the American College of Radiology, the USPSTF, and KFF. This is a cost comparison, not medical advice — talk to a qualified, licensed clinician about which screening tests are right for you before any decision.
📋 Or get the free Medical Travel Cost Checklist — no email →
View provenance manifest for this video →
You shouldn't have to go broke to feel whole.
